| Literature DB >> 33633400 |
Jingwei Zeng1, Ana Filipa Santos2, Aamir S Mukadam3, Mariana Osswald2, David A Jacques4, Claire F Dickson4, Stephen H McLaughlin1, Christopher M Johnson1, Leo Kiss1, Jakub Luptak1, Nadine Renner1, Marina Vaysburd1, William A McEwan5, Eurico Morais-de-Sá6, Dean Clift7, Leo C James8.
Abstract
Trim-Away is a recently developed technology that exploits off-the-shelf antibodies and the RING E3 ligase and cytosolic antibody receptor TRIM21 to carry out rapid protein depletion. How TRIM21 is catalytically activated upon target engagement, either during its normal immune function or when repurposed for targeted protein degradation, is unknown. Here we show that a mechanism of target-induced clustering triggers intermolecular dimerization of the RING domain to switch on the ubiquitination activity of TRIM21 and induce virus neutralization or drive Trim-Away. We harness this mechanism for selective degradation of disease-causing huntingtin protein containing long polyglutamine tracts and expand the Trim-Away toolbox with highly active TRIM21-nanobody chimeras that can also be controlled optogenetically. This work provides a mechanism for cellular activation of TRIM RING ligases and has implications for targeted protein degradation technologies.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33633400 PMCID: PMC7611929 DOI: 10.1038/s41594-021-00560-2
Source DB: PubMed Journal: Nat Struct Mol Biol ISSN: 1545-9985 Impact factor: 15.369